Aligos Therapeutics, Inc.
ALGS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001799448
No open-market purchases or sales by Aligos Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $13.2M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
13F holders, Q2 2026
Institutional positions in Aligos Therapeutics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- −4 vs. Q1 2026
- Shares held
- 2.29M
- −482.6K (−17.4%) vs. Q1 2026
- Total value
- $13.2M
- −$7.39M (−35.8%) vs. Q1 2026
- New holders
- 5
- 7 more added
- Sold out
- 9
- 7 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALGS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 31 | $13.2M |
| Q1 2026 | 35 | $20.6M |
| Q4 2025 | 41 | $26.2M |
| Q3 2025 | 33 | $26.0M |
| Q2 2025 | 37 | $19.5M |
| Q1 2025 | 35 | $27.1M |
| Q4 2024 | 34 | $64.5M |
| Q3 2024 | 27 | $14.7M |
| Q2 2024 | 49 | $16.6M |
| Q1 2024 | 49 | $45.3M |
| Q4 2023 | 40 | $30.1M |
| Q3 2023 | 36 | $19.2M |
| Q2 2023 | 41 | $25.5M |
| Q1 2023 | 46 | $23.9M |
| Q4 2022 | 39 | $25.3M |
| Q3 2022 | 52 | $30.4M |
| Q2 2022 | 60 | $36.0M |
| Q1 2022 | 76 | $68.4M |
| Q4 2021 | 71 | $390.4M |
| Q3 2021 | 68 | $483.9M |
| Q2 2021 | 58 | $550.5M |
| Q1 2021 | 52 | $612.4M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Aligos Therapeutics, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BNP Paribas Arbitrage, SA | 3 | $17 | 0.00% | 00.0% | Unchanged |
| ZRC Wealth Management, LLC | 4 | $24 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 10 | $58 | 0.00% | +10 | New |
| Wells Fargo & Company | 100 | $577 | 0.00% | −600−85.7% | Reduced |
| SBI Securities Co., Ltd. | 126 | $727 | 0.00% | +100+384.6% | Added |
| Morgan Stanley | 204 | $1.18K | 0.00% | −14−6.4% | Reduced |
| JPMorgan Chase & Co | 344 | $1.87K | 0.00% | −330−49.0% | Reduced |
| Tower Research Capital LLC (TRC) | 359 | $2.07K | 0.00% | +294+452.3% | Added |
| Citigroup Inc | 1,808 | $10.4K | 0.00% | +1,808 | New |
| Royal Bank of Canada | 2,125 | $12.0K | 0.00% | 00.0% | Unchanged |
| Golden State Wealth Management, LLC | 2,674 | $15.4K | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 4,650 | $26.8K | 0.00% | +3,700+389.5% | Added |
| Rockefeller Capital Management L.P. | 10,000 | $57.7K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 10,800 | $62.3K | 0.00% | −89,650−89.2% | Reduced |
| Trexquant Investment LP | 12,339 | $71.2K | 0.00% | +12,339 | New |
| Verition Fund Management LLC | 18,887 | $109.0K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 21,044 | $121.4K | 0.00% | +21,044 | New |
| Vanguard Fiduciary Trust Co | 28,612 | $165.1K | 0.00% | +175+0.6% | Added |
| BlackRock, Inc. | 30,292 | $174.8K | 0.00% | +17,252+132.3% | Added |
| Jane Street Group, LLC | 32,402 | $187.0K | 0.00% | +32,402 | New |
| Geode Capital Management, LLC | 47,173 | $272.3K | 0.00% | −2,802−5.6% | Reduced |
| UBS Group AG | 59,986 | $346.1K | 0.00% | +22,925+61.9% | Added |
| D. E. Shaw & Co., Inc. | 66,463 | $383.5K | 0.00% | +55,485+505.4% | Added |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 76,247 | $439.9K | 0.05% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 83,055 | $479.2K | 0.00% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 175,543 | $1.01M | 0.00% | −2,719−1.5% | Reduced |
| Woodline Partners LP | 177,362 | $1.02M | 0.00% | 00.0% | Unchanged |
| Marshall Wace, LLP | 246,579 | $1.42M | 0.00% | −20,556−7.7% | Reduced |
| Sio Capital Management, LLC | 327,237 | $1.89M | 0.32% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 412,000 | $2.38M | 0.01% | 00.0% | Unchanged |
| Deep Track Capital, LP | 444,110 | $2.56M | 0.04% | 00.0% | Unchanged |
| Bank of America Corp | 0 | $0 | 0.00% | −229,754−100.0% | Sold out |
| SummitTX Capital, L.P. | 0 | $0 | 0.00% | −148,799−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −54,311−100.0% | Sold out |
| LPL Financial LLC | 0 | $0 | 0.00% | −51,500−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −23,093−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −14,196−100.0% | Sold out |
| Quadrature Capital Ltd | 0 | $0 | 0.00% | −10,822−100.0% | Sold out |
| Vanguard Global Advisers, LLC | 0 | $0 | 0.00% | −936−100.0% | Sold out |
| Fortitude Family Office, LLC | 0 | $0 | 0.00% | −68−100.0% | Sold out |